NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses.

J Nanobiotechnology · 2021 · PMC8130144 · PMID 34001148

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

With the increase of the irradiation time from 6 to 7 min, the release of HMGB1 in HA-PDA@IQ/DOX group showed an increasing trend and was stable around 1.40 μg/mL.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.